A SUVmax-based propensity matched analysis of stereotactic body radiotherapy versus surgery in stage I non-small cell lung cancer: unveiling the role of 18F-FDG PET/CT in clinical decision-making | |
Jin, X.; Ye, L.; Xu, F.; Shi, S.; Zeng, Z.; Huang, Y.; Lu, C.; Gu, J.; Ge, D.; He, J. | |
刊名 | CLINICAL & TRANSLATIONAL ONCOLOGY |
2018 | |
卷号 | 20期号:8 |
关键词 | Non-small cell lung cancer Stereotactic body radiotherapy Surgery Comparative effectiveness research PET-CT |
ISSN号 | 1699-048X |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3600026 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Jin, X.,Ye, L.,Xu, F.,et al. A SUVmax-based propensity matched analysis of stereotactic body radiotherapy versus surgery in stage I non-small cell lung cancer: unveiling the role of 18F-FDG PET/CT in clinical decision-making[J]. CLINICAL & TRANSLATIONAL ONCOLOGY,2018,20(8). |
APA | Jin, X..,Ye, L..,Xu, F..,Shi, S..,Zeng, Z..,...&He, J..(2018).A SUVmax-based propensity matched analysis of stereotactic body radiotherapy versus surgery in stage I non-small cell lung cancer: unveiling the role of 18F-FDG PET/CT in clinical decision-making.CLINICAL & TRANSLATIONAL ONCOLOGY,20(8). |
MLA | Jin, X.,et al."A SUVmax-based propensity matched analysis of stereotactic body radiotherapy versus surgery in stage I non-small cell lung cancer: unveiling the role of 18F-FDG PET/CT in clinical decision-making".CLINICAL & TRANSLATIONAL ONCOLOGY 20.8(2018). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论